BioGaia is a leading company in probiotic research and development, focusing on the health benefits of probiotics for individuals at all stages of life. Their product range includes probiotics specifically designed for adults, children, and infants, showcasing a commitment to enhancing gut health and overall well-being. BioGaia's probiotics are clinically proven, with a minimum of 100 million live bacteria in each daily dose, reflecting their dedication to scientific rigor and efficacy. The company emphasizes the importance of good bacteria in maintaining health, supported by over 30 years of research and development in the field.

Among their innovative products, BioGaia offers specialized formulations such as the Prodentis lozenges, which contain patented strains of Lactobacillus reuteri aimed at improving oral health. These lozenges are designed to be a convenient addition to daily oral hygiene routines, promoting healthy gums and fresh breath. BioGaia's commitment to quality is evident in their use of high-quality ingredients and their focus on clinically validated benefits, making their probiotics a trusted choice for consumers seeking to support their health through scientifically backed solutions.

Sweden

BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 30 years. BioGaia develops, markets and sells probiotic products within the areas of gut, oral, immune and bone health. Our probiotic products with bacterial strains from the L. reuteri species are among the most scientifically well-documented probiotics. The class B share of BioGaia is quoted on the Mid Cap list of the Nordic Exchange Stockholm.

BioGaia

Company Details